http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#Head http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#assertion http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#provenance http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#pubinfo http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#assertion http://purl.obolibrary.org/obo/DOID_5419 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_5419 http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB04946 http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#association http://www.w3.org/2000/01/rdf-schema#label fanapt r see clinical studies 14 when deciding among the alternative treatments available for this condition the prescriber should consider the finding that fanapt see warnings and precaution s 5 2 patients must be titrated to an effective dose of fanapt s ee dosage and administration 2 1 and clinical studies 14 the effectiveness of fanapt in long term use that is for more than 6 weeks has not been systematically evaluated in controlled trials therefore the physician who elects to use fanapt for extended periods should periodically re evaluate the long term usefulness of the drug for the individual patient s ee dosage and administration 2 3 fanapt is an atypical antipsychotic agent indicated for the treatment of schizophrenia in adults 1 14 http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB04946 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#provenance http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#pubinfo http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#sig http://purl.org/nanopub/x/hasSignature LAWb6yYRdhbvj0frGpxVWRSuBuWqf5ZYjKBNw8hs3syZydbXSyWWNzP4Il6Jt0hW2S0RxPhk56qLx89Z/0RN5tU0PeV9vjBeyhAURmPmZBbPfaGJ9mSKUsOaWzi0BwWiXOSjFfEkJY8qie/IkZ2xiigG4BVzf861nFYy4Trz+ik= http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg http://purl.org/dc/terms/created 2021-07-03T11:41:09.959+02:00 http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs